Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Short Interest Up 31.8% in March

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,740,000 shares, an increase of 31.8% from the February 29th total of 1,320,000 shares. Approximately 9.6% of the shares of the stock are short sold. Based […]

Related Keywords

,Syros Pharmaceuticals Stock Down ,Syros Pharmaceuticals Company Profile ,Syros Pharmaceuticals ,Syros Pharmaceuticals Inc ,Nasdaq ,Advisor Group ,Institutional Investors Weigh In On Syros Pharmaceuticals ,News Ratings For Syros Pharmaceuticals Daily ,Prudential Financial Inc ,Sawtooth Solutions ,Get Free Report ,Pharmaceuticals Stock Down ,Two Sigma Investments ,Sigma Investments ,Syros Pharmaceuticals Daily ,Nasdaq Syrs ,Syrs ,Medical ,Stocks ,Options ,Put ,Call ,